3 results match your criteria: "Topiwala Nair Medical College and BYL Nair Hospital[Affiliation]"
Saudi J Kidney Dis Transpl
March 2022
Department of Nephrology, Topiwala Nair Medical College and BYL Nair Hospital, Mumbai, Maharashtra, India.
We aimed to study the effect of remdesivir therapy on renal and hepatic function in coronavirus disease-2019 (COVID-19) patients with renal dysfunction at baseline or after starting therapy and identify the factors, if any, related to the efficacy of remdesivir therapy on patient outcome. Patients included in the study were those who met all the following criteria irrespective of baseline glomerular filtration rate [including those already on maintenance hemodialysis (HD)] or baseline deranged liver function test. (1) Age >18 years, (2) COVID-19 reverse transcriptase-polymerase chain reaction positive, (3) Meeting criteria for administration of remdesivir - [any one of the following: (a) COVID-19 pneumonia with respiratory rate >30/min or SPO<94% on room air, (b) Acute respiratory distress syndrome (ARDS)].
View Article and Find Full Text PDFIndian J Nephrol
March 2021
Department of Nephrology, Topiwala Nair Medical College and BYL Nair Hospital, Mumbai, Maharashtra, India.
Introduction: CKD5D is a high risk subgroup with high comorbidity burden, need for frequent visits to dialysis centre and a compromised immune system. The effect of SARS COV2 virus on this population is not well known.
Methods: This prospective study enrolled, all CKD5D with COVID 19 infection, admitted to our hospital, from 23 April to 30 June 2020 & whose outcome as discharge/mortality was known.
Indian J Orthop
April 2020
4Bone and Soft Tissue Services, Tata Memorial Hospital, Mumbai, India.
Background: This study aimed at evaluating the imaging findings of phosphaturic mesenchymal tumors and tumor-induced osteomalacia and assess the clinical and biochemical profiles of patients with tumor-induced osteomalacia.
Materials And Methods: Imaging findings in six patients with tumor-induced osteomalacia and histopathologically proven phosphaturic mesenchymal tumors were evaluated. Clinical and biochemical profiles of these patients were also assessed.